- Home
- CNSP vs SGD Comparison
CNSP vs SGD Comparison
Compare CNSP & SGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNSP
- SGD
- Stock Information
- Founded
- CNSP 2017
- SGD 2021
- Country
- CNSP United States
- SGD United States
- Employees
- CNSP N/A
- SGD N/A
- Industry
- CNSP Biotechnology: Pharmaceutical Preparations
- SGD
- Sector
- CNSP Health Care
- SGD
- Exchange
- CNSP Nasdaq
- SGD Nasdaq
- Market Cap
- CNSP 4.0M
- SGD 4.4M
- IPO Year
- CNSP 2019
- SGD N/A
- Fundamental
- Price
- CNSP $8.39
- SGD $1.04
- Analyst Decision
- CNSP Strong Buy
- SGD
- Analyst Count
- CNSP 1
- SGD 0
- Target Price
- CNSP $20.00
- SGD N/A
- AVG Volume (30 Days)
- CNSP 25.2K
- SGD 588.8K
- Earning Date
- CNSP 11-14-2025
- SGD 11-22-2025
- Dividend Yield
- CNSP N/A
- SGD N/A
- EPS Growth
- CNSP N/A
- SGD N/A
- EPS
- CNSP N/A
- SGD N/A
- Revenue
- CNSP N/A
- SGD $1,536,255.00
- Revenue This Year
- CNSP N/A
- SGD N/A
- Revenue Next Year
- CNSP N/A
- SGD N/A
- P/E Ratio
- CNSP N/A
- SGD N/A
- Revenue Growth
- CNSP N/A
- SGD 1570.24
- 52 Week Low
- CNSP $4.93
- SGD $0.65
- 52 Week High
- CNSP $114.00
- SGD $3.72
- Technical
- Relative Strength Index (RSI)
- CNSP 44.14
- SGD 40.14
- Support Level
- CNSP $8.09
- SGD $0.88
- Resistance Level
- CNSP $9.30
- SGD $1.26
- Average True Range (ATR)
- CNSP 0.55
- SGD 0.16
- MACD
- CNSP -0.27
- SGD -0.03
- Stochastic Oscillator
- CNSP 5.95
- SGD 20.29
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
About SGD Safe and Green Development Corporation
Safe & Green Development Corp is a real estate development company that focuses on the development of sites using purpose built, prefabricated modules built from both wood & steel, sourced from one of Safe and Green Holdings factories. The company's business model is flexible and it anticipates developing properties on its own and also through joint ventures in which it partners with third-party equity investors or other developers.